Bristol-Myers Squibb (BMY)
61.12
1.10 (1.83%)
At close: Mar 31, 2025, 3:59 PM
60.87
-0.40%
After-hours: Mar 31, 2025, 07:46 PM EDT
Abraxane Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 258M | 19M | +7.95% |
| Mar 31, 2023 | 239M | 60M | +33.52% |
| Dec 31, 2022 | 179M | 2M | +1.13% |
| Sep 30, 2022 | 177M | -64M | -26.56% |
| Jun 30, 2022 | 241M | 27M | +12.62% |
| Mar 31, 2022 | 214M | -91M | -29.84% |
| Dec 31, 2021 | 305M | 39M | +14.66% |
| Sep 30, 2021 | 266M | -30M | -10.14% |
| Jun 30, 2021 | 296M | -2.59B | -89.74% |
| Mar 31, 2021 | 2.89B | 617M | +27.19% |
| Dec 31, 2020 | 2.27B | 174M | +8.31% |
| Sep 30, 2020 | 2.1B | -68M | -3.14% |
| Jun 30, 2020 | 2.16B | -478M | -18.10% |
| Mar 31, 2020 | 2.64B | 878M | +49.80% |
| Dec 31, 2019 | 1.76B | -54M | -2.97% |
| Sep 30, 2019 | 1.82B | -6M | -0.33% |
| Jun 30, 2019 | 1.82B | 22M | +1.22% |
| Mar 31, 2019 | 1.8B | -3M | -0.17% |
| Dec 31, 2018 | 1.8B | 11M | +0.61% |
| Sep 30, 2018 | 1.79B | 166M | +10.20% |
| Jun 30, 2018 | 1.63B | 116M | +7.68% |
| Mar 31, 2018 | 1.51B | 150M | +11.02% |
| Dec 31, 2017 | 1.36B | 96M | +7.59% |
| Sep 30, 2017 | 1.26B | 70M | +5.86% |
| Jun 30, 2017 | 1.2B | 68M | +6.03% |
| Mar 31, 2017 | 1.13B | -183M | -13.97% |
| Dec 31, 2016 | 1.31B | 390M | +42.39% |
| Sep 30, 2016 | 920M | 80M | +9.52% |
| Jun 30, 2016 | 840M | 136M | +19.32% |
| Mar 31, 2016 | 704M | 229M | +48.21% |
| Dec 31, 2015 | 475M | 170M | +55.74% |
| Sep 30, 2015 | 305M | 183M | +150.00% |
| Jun 30, 2015 | 122M | 82M | +205.00% |
| Mar 31, 2015 | 40M | 35M | +700.00% |
| Dec 31, 2014 | 5M | 4M | +400.00% |
| Sep 30, 2014 | 1M | -401M | -99.75% |
| Jun 30, 2014 | 402M | 39M | +10.74% |
| Mar 31, 2014 | 363M | -354M | -49.37% |
| Dec 31, 2013 | 717M | 401M | +126.90% |
| Sep 30, 2013 | 316M | -36M | -10.23% |
| Jun 30, 2013 | 352M | n/a | n/a |